Moolec Science SA

Moolec Science’s insider derivative move signals confidence in its plant‑protein platform amid a steep market decline, hinting at potential upside.

Moolec Science insiders’ derivative holdings reveal CFO confidence in its plant‑protein future, offering a bullish long‑term view amid market volatility.

General Counsel’s 1,909‑share stake shows Moolec Science’s leadership confidence despite a 91% drop, hinting at long‑term faith in its protein tech.